⌕
Dr. Reddy's Laboratories · RDY · NYSE
Tenet 45 · Mixed
Compare
$14.79+0.61%At closeTenet 45 · Mixed
$14.79+0.09 (+0.61%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Dr. Reddy's Laboratories (RDY) Stock Checks

How RDY measures up against value, income, timing, and long-hold tenets. Every criterion shows the number as of the last close and the pass rule. Always free.

Sources Company filings and computed by Tenet Filings and TenetScreens as of How we compute thisNot investment advice

The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).

0 / 17 qualify todayas of close, Nov 16, 2026 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
0
meet every gate today
BORDERLINE
10
within one input of the gate
FAILS
5
miss at least one gate
UNKNOWN
2
insufficient data to judge
Buffett Qualitydurable moat
~ Borderline
PassesROE ≥ 15%23.0% · ≥ 15.0%
PassesGross margin ≥ 40%52.8% · ≥ 40.0%
FailsNet margin ≥ 15%12.6% · ≥ 15.0%
PassesDebt/equity ≤ 0.50.20 · ≤ 0.50
Unknown — no dataGrowing FCF (multi-yr)— · > 0
Decided by the pass rule for Buffett Quality.
The pass rule for Buffett Quality is what decides that verdict, and it is not restated here. 1 of 5 carry no data.Buffett Quality under The screens ›Today's Buffett Quality list ›
PassesReturn on assets positive7.3% · > 0
PassesOperating cash flow positive$607.0M · > 0
FailsReturn on assets improvingWe hold no record of return on assets for both years for this company, so this signal could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.n/a → 7.3%
PassesEarnings backed by cash (CFO > net income)$607.0M vs $452.0M
FailsLeverage falling (long-term debt / assets)We hold no record of long-term debt as a share of assets for both years for this company, so this signal could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.n/a → 2.1%
FailsCurrent ratio improvingWe hold no record of the current ratio for both years for this company, so this signal could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.n/a → 1.80
PassesNo share dilution (≤ +2%)+0.0%
FailsGross margin expandingThe reported cost of revenue collapses to a level implying a 100% gross margin, which we treat as a data artefact rather than a real margin, so gross margin could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.n/a → 52.8%
FailsAsset turnover improvingWe hold no record of asset turnover for both years for this company, so this signal could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.n/a → 0.58
Decided by the pass rule for Piotroski F-Score.
The pass rule for Piotroski F-Score is what decides that verdict, and it is not restated here. 5 of 9 carry no data.Piotroski F-Score under The screens ›Today's Piotroski F-Score list ›
FailsROIC ≥ 15%8.8% · ≥ 15.0%
PassesNet debt/EBITDA ≤ 3×−0.2× · ≤ 3.0×
PassesAltman Z ≥ 3 (safe zone)5.47 · ≥ 3.00
Decided by the pass rule for Munger Compounders.
The pass rule for Munger Compounders is what decides that verdict, and it is not restated here.Munger Compounders under The screens ›Today's Munger Compounders list ›
PassesEBIT > 0$539.0M · > 0
FailsEarnings yield EBIT/EV ≥ 6%4.4% · ≥ 6.0%
FailsReturn on capital ≥ 25%20.2% · ≥ 25.0%
Decided by the pass rule for Magic Formula.
The pass rule for Magic Formula is what decides that verdict, and it is not published separately on the methodology page.About this screen ›Today's Magic Formula® list ›
PassesSize: market cap ≥ $2B$12.3B · ≥ $2.0B
FailsCurrent ratio ≥ 21.80 · ≥ 2.00
PassesPositive EPS 10y10y
PassesPays a dividend$0.08 · > 0
Unknown — no dataEPS growth ≥ 3%/yr— · ≥ 3.0%
FailsP/E ≤ 1527.14 · ≤ 15.00
FailsP/E × P/B ≤ 22.585.46 · ≤ 22.50
Decided by the pass rule for Graham Defensive.
The pass rule for Graham Defensive is what decides that verdict, and it is not restated here. 1 of 7 carry no data.Graham Defensive under The screens ›Today's Graham Defensive list ›
Unknown — no dataPEG < 1 (hist. growth)— · < 1.00
Unknown — no dataEPS growth 10–30%— · 10.0%–30.0%
Verdict Unknown for this set.
Verdict Unknown for this set. None of the 2 checks below carry data.Lynch GARP under The screens ›Today's Lynch GARP list ›
PassesPays a dividend$0.08 · > 0
FailsYield in a healthy band (not a yield trap)0.6% · 1.0%–8.0%
PassesCovered by free cash flow2.77 · ≥ 1.20
PassesEarnings payout not stretched15.7% · ≤ 75.0%
PassesBalance sheet can sustain the payout−0.2× · ≤ 4.0×
FailsAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)0.00 · ≥ 10.00
FailsNo dividend cut in the last 5 yearsLast cut 2024
Passes5-year dividend growth ≥ 5%/yr6.5% · ≥ 5.0%
Decided by the pass rule for Income & Dividend Safety.
The pass rule for Income & Dividend Safety is what decides that verdict, and it is not published separately on the methodology page.
PassesPays a dividend$0.08 · > 0
FailsAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)0.00 · ≥ 10.00
FailsNo dividend cut in the last 5 yearsLast cut 2024
Passes5-year dividend growth ≥ 5%/yr6.5% · ≥ 5.0%
PassesCovered by free cash flow2.77 · ≥ 1.20
PassesPayout not stretched15.7% · ≤ 75.0%
Decided by the pass rule for Dividend Growth.
The pass rule for Dividend Growth is what decides that verdict, and it is not restated here.Dividend Growth under The screens ›Today's Dividend Growth list ›
FailsReturn on invested capital ≥ 15% in 4+ of the last 5 years0 of 2 on file
FailsRevenue compounding ≥ 8%/yr over 5 years−64.1% · ≥ 8.0%
PassesNot diluting: diluted share count flat-to-down (≤ +1%/yr)0.1% · ≤ 1.0%
FailsFree cash flow margin ≥ 12%5.5% · ≥ 12.0%
PassesEarnings backed by cash (operating cash flow ≥ net income)1.34 · ≥ 1.00
Reading: does not hold. Not a gate checkDisciplined buybacks: actively reducing the share count (bonus)reading, not a gate check0.1%
Decided by the pass rule for Quality Compounder.
The pass rule for Quality Compounder is what decides that verdict, and it is not restated here. Lines marked as readings are published beside the checks and are not gate checks.Quality Compounder under The screens ›Today's Quality Compounder list ›
FailsOff its 52-week high by 8–35% (a dip, not a collapse)6.2% · 8.0%–35.0%
PassesDip within its own normal pullback band0.07
PassesNot past where its dips have historically recovered from−1.42
PassesA dip in an uptrend (above a rising 200-day)13.29
PassesHigher-low structure still intactstructure intact · higher low
Unknown — no dataClear of the earnings blackout (more than 5 days out)— · > 5.00
Decided by the pass rule for Drawdown Context.
The pass rule for Drawdown Context is what decides that verdict, and it is not published separately on the methodology page. 1 of 6 carry no data.
Unknown — no dataA bullish MACD cross within 10 sessions— · ≤ 10.00
PassesReclaimed a rising 50-day EMA13.50
PassesPrinted a higher lowyes
FailsA volume thrust on the turn (≥ 1.2× normal)1.07 · ≥ 1.20
FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)2.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.
The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page. 1 of 5 carry no data.
Unknown — no dataIn the cheap half of its own 5-year valuation range—
PassesEarnings estimates not being cut0.02
Unknown — no dataReturns on capital not deteriorating0.09
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 3 checks below carry data. The pass rule for Not-a-Value-Trap Gate is not published separately on the methodology page.
PassesOperating profit is positive$539.0M · > 0
FailsReturn on invested capital ≥ 10%8.8% · ≥ 10.0%
PassesA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)5.5×
PassesQuality score ≥ 5056.80 · ≥ 50.00
FailsRevenue growing over 5 years−64.1% · > 0
Decided by the pass rule for Quality Floor.
The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page.
A research signal from published criteria, not a recommendation.
FailsDrawdown context6.2% off its 52-week high
FailsReversal evidence2 of 4 signals fired
Unknown — no dataTrap gate1 of 3 held · 2 no data
FailsQuality floor3 of 5 held
Invalidation level (structure break): below this the dip's structure has broken$11.55
Decided by the pass rule for Qualified Dip.
The pass rule for Qualified Dip is what decides that verdict, and it is not restated here. 1 of 4 carry no data.Qualified Dip under The screens ›Today's Qualified Dip list ›
PassesTrading above its 50-day average13.10
PassesTrading above its 200-day average13.29
Fails50-day average above the 200-day (uptrend stack)13.10
Passes50-day average sloping up0.07 · > 0
Decided by the pass rule for Trend Alignment.
The pass rule for Trend Alignment is what decides that verdict, and it is not published separately on the methodology page.
Passes3-month return in the top half of the universe0.94 · ≥ 0.50
Fails12-minus-1 momentum in the top half of the universe0.31 · ≥ 0.50
PassesRelative strength vs the S&P 500 improving0.00 · > 0
PassesEarnings estimates being revised up0.02
Decided by the pass rule for Relative Strength.
The pass rule for Relative Strength is what decides that verdict, and it is not published separately on the methodology page.
FailsMACD above its signal line0.52
Not scored: see the reason belowBack above the 50-day on a fresh cross (≤10 sessions)This is a two-part reading (price back above the 50-day, and a bullish momentum cross inside 10 sessions) and a dated momentum cross is not on record for this name yet, so it is left unscored rather than counted either way.—
PassesHigher high and higher low (stair-stepping up)higher high · higher low
FailsA volume thrust on the move (≥ 1.2× normal)1.07 · ≥ 1.20
Decided by the pass rule for Momentum Trigger.
The pass rule for Momentum Trigger is what decides that verdict, and it is not published separately on the methodology page. 1 of 4 carry no data.
Average daily swing: normal0.02
Volatility band width: expanded (wide range)0.84
Distance from its 52-week high: a modest pullback0.06
Every verdict is auditableEach criterion shows the number as of the last close and the pass rule side by side: a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.

How many investing rule sets does Dr. Reddy's Laboratories pass?

Dr. Reddy's Laboratories qualifies on 0 of 17 rule sets as of 2026-11-16, with 10 borderline and 5 failing.

Does Dr. Reddy's Laboratories meet the Graham Defensive criteria?

Dr. Reddy's Laboratories fails the Graham Defensive rule set as of 2026-11-16.

Does Dr. Reddy's Laboratories meet the Buffett Quality criteria?

Dr. Reddy's Laboratories is borderline on the Buffett Quality rule set as of 2026-11-16.

Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.